Global reflexology for pain relief in children with sickle cell disease
Exploratory Study on Global Reflexology Proposed in the Management of Pain in Children With Sickle Cell Disease in Vaso-occlusive Crisis
Try global reflexology to see if it reduces pain in children under 18 hospitalized for sickle cell vaso-occlusive crises.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Trial ID | NCT06619197 on ClinicalTrials.gov |
What this trial studies
This interventional exploratory program applies global reflexology to children with sickle cell disease who are admitted for vaso-occlusive crises. Trained childcare staff will deliver reflexology sessions during hospitalization with parental consent and the child's assent when appropriate. The protocol excludes patients on patient-controlled or nurse-controlled analgesia and focuses on those treated in the UHCD or USC units. Pain and clinical course during the hospital stay will be monitored to detect any change associated with the reflexology sessions.
Who should consider this trial
Good fit: Children under 18 with sickle cell disease who are hospitalized in the UHCD or USC units of Hôpital Femme Mère Enfant (Hospices Civils de Lyon) for management of a vaso-occlusive crisis, with parental consent and patient assent as appropriate.
Not a fit: Patients receiving patient-controlled or nurse-controlled analgesia, adults, or those not hospitalized in the specified units are not eligible and therefore unlikely to benefit from this protocol.
Why it matters
Potential benefit: If effective, this could reduce acute pain during vaso-occlusive crises and provide a simple non-drug technique usable by paramedical staff.
How similar studies have performed: A small 2013 case series of 12 sickle cell patients reported pain reduction in eight patients after reflexology, but larger controlled trials confirming benefit are lacking.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient under 18 years of age * Patient suffering from sickle cell disease * Patient hospitalized in the UHCD or USC unit of the Women\'s Mother and Child Hospital of the Hospices Civils de Lyon for the management of a CVO * Informed consent signed by at least one holder of parental authority * Collection of the patient\'s assent as soon as his age allows it. Exclusion Criteria: * Patient with PCA (Patient Controlled Analgesia) * Patient with NCA (Nurse Controlled Analgesia) * Patient not affiliated to a social security scheme or beneficiaries of a similar scheme.
Where this trial is running
Bron
- Hôpital Femme Mère Enfant — Bron, France (Recruiting)
Study contacts
- Principal investigator: Collot Sophie — Hospices Civils de Lyon
- Study coordinator: COLLOT Sophie
- Email: sophie.collot@chu-lyon.fr
- Phone: 0033472115165
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.